Hosted on MSN

Vertex Gets EU Nod for New Cystic Fibrosis Drug Alyftrek

Per management, Alyftrek has the potential to provide better patient benefits than Trikafta and become a new standard-of-care treatment in CF. It can possibly treat CF patients who have discontinued ...
STAT

State Prescription Drug Affordability Boards could end up limiting access to the life-saving cystic fibrosis medication Trikafta

I was living on the precipice of end-stage disease when I enrolled in the clinical trial that resulted in the historically fast Food and Drug Administration approval for the game-changing cystic ...

Yukon gov't working to add new cystic fibrosis medication to its drug plan

The Yukon government says work is underway to add cystic fibrosis drug Alyftrek to its drug formulary. This comes as ...
FiercePharma

Vertex's Trikafta pricing central to cystic fibrosis treatment disparities, study says

The cost of a popular Vertex Pharmaceuticals therapy could be contributing to cystic fibrosis (CF) treatment disparities around the world, researchers argued in a recent paper. Just 12% of some ...
Yahoo Finance

Vertex's (VRTX) Trikafta Gets FDA Nod for CF in Children

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Business Wire

ADDING MULTIMEDIA FDA Approves TRIKAFTA (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to Treat the Underlying Cause of Cystic Fibrosis in People Ages 12 and Older Who Have ...

- For the first time, approximately 6,000 patients with one minimal function mutation and one F508del mutation have a medicine to treat the underlying cause of their disease– -12,000 people with one ...
FiercePharma

JPM 2022: Vertex's Trikafta holds the line as company lays groundwork for gene editing launch

Vertex Pharmaceuticals is well known for its slew of cystic fibrosis medications, and newcomer Trikafta is pulling its weight. Over the course of 2021, the med clinched reimbursement in 16 countries ...
Yahoo

ATS 2026: Long-term data show durable benefit of Trikafta for cystic fibrosis

Add Yahoo as a preferred source to see more of our stories on Google. Positive Trikafta results set a benchmark of efficacy for future CF therapies. Photo by filadendron/E+ via Getty Images. On 18 May ...
Nasdaq

Vertex's (VRTX) Trikafta NDA Gets Priority Review by FDA

Vertex Pharmaceuticals Inc. VRTX announced that the FDA has accepted its supplemental new drug application (sNDA) for the label expansion of its triple combination ...
Nasdaq

Vertex Receives Australian TGA Approval for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to Treat People With Cystic Fibrosis Ages 12 Years and Older Who Have At ...

- With this approval approximately 750 people living with cystic fibrosis in Australia will be newly eligible for a CFTR modulator therapy - CF affects approximately 3,500 people in Australia. It is ...
Newsday

Health experts say new drug Trikafta a game-changer for cystic fibrosis patients

Courtney Boccio wasn’t sure what to expect when she started a clinical trial for a new drug aimed at helping people with cystic fibrosis in the spring of 2018. The 25-year-old Huntington woman was ...